When people have had diabetes for a while the counter regulatory system isimpaired. Also sleep dampens the responses. Continuous glucose monitoring hasnot found evidence of the so called Somogyi phenomenon. Unfortunately somehospitals are still repeating this myth http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Retrieve&dopt=Abstract&list_uids=17652003 Nocturnal hypoglycaemias in type 1 diabetic patients: what can we learn withcontinuous glucose monitoring? Guillod L, Comte-Perret S, Monbaron D, Gaillard RC, Ruiz J. Service of Endocrinology, Diabetology and Metabolism,Centre HospitalierUniversitaire Vaudois, 1011, Lausanne, Switzerland. AIM: In type 1 diabetic patients (T1DM), nocturnal hypoglycaemias (NH) are aserious complication of T1DM treatment; self-monitoring of blood glucose (SMBG)is recommended to detect them. However, the majority of NH remains undetected onan occasional SMBG done during the night. An alternative strategy is theContinuous glucose monitoring (CGMS), which retrospectively shows the glycaemicprofile. The aims of this retrospective study were to evaluate the trueincidence of NH in T1DM, the best SMBG time to predict NH, the relationshipbetween morning hyperglycaemia and NH (Somogyi phenomenon) and the utility ofCGMS to reduce NH. METHODS: Eighty-eight T1DM who underwent a CGMS exam wereincluded. Indications for CGMS evaluation, hypoglycaemias and correlation withmorning hyperglycaemias were recorded. The efficiency of CGMS to reduce thesuspected NH was evaluated after 6-9 months. RESULTS: The prevalence of NH was67% (32% of them unsuspected). A measured hypoglycaemia at bedtime (22-24 h) hada sensitivity of 37% to detect NH (OR=2.37, P=0.001), while a single measure <or =4 mmol/l at 3-hour had a sensitivity of 43% (OR=4.60, P<0.001). NH were notassociated with morning hyperglycaemias but with morning hypoglycaemias(OR=3.95, P<0.001). After 6-9 months, suspicions of NH decreased from 60 to 14%(P<0.001). CONCLUSION: NH were highly prevalent and often undetected. SMBG atbedtime, which detected hypoglycaemia had sensitivity almost equal to that of3-hour and should be preferred because it is easier to perform. Somogyiphenomenon was not observed. CGMS is useful to reduce the risk of NH in 75% ofpatients. Defective Awakening Response to Nocturnal Hypoglycemia in Patients with Type 1Diabetes Mellitus http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040069 We tested two groups of 16 T1DM patients and 16 healthy control participants,respectively, with comparable distributions of gender, age, and body mass index.In one night, a linear fall in plasma glucose to nadir levels of 2.2 mmol/l wasinduced by infusing insulin over a 1-h period starting as soon aspolysomnographic recordings indicated that stage 2 sleep had been reached. Inanother night (control), euglycemia was maintained. Only one of the 16 T1DM patients, as compared to ten healthy controlparticipants, awakened upon hypoglycemia (p = 0.001). In the control nights,none of the study participants in either of the two groups awakened during thecorresponding time. Awakening during hypoglycemia was associated with increasedhormonal counterregulation. In all the study participants (from both groups) whowoke up, and in five of the study participants who did not awaken (three T1DMpatients and two healthy control participants), plasma epinephrine concentrationincreased with hypoglycemia by at least 100% (p < 0.001). A temporal pattern wasrevealed such that increases in epinephrine in all participants who awakenedstarted always before polysomnographic signs of wakefulness (mean ? standarderror of the mean: 7.5 ? 1.6 min).
I got this from another forum and found it interesting so thought you may like to read it too. Bev
I got this from another forum and found it interesting so thought you may like to read it too. Bev